posted
Insiders are loading up on XKEM.See below for post from IHub.
Posted by: thewallmaster In reply to: None Date:2/22/2006 12:32:27 PM Post #of 321
XKEM ----- Insiders Buying !!!!! ----- last 7 days ----- 6 green 1 Red --------XKEM the next runner! Our new pick for 22/FEB/2006 is =(XKEM) was picked up of (INSIDER BUYING) Accumulation........is the key word
Xechem International,Inc, Ticker Symbol = XKEM Market Cap = $ 1. 90M Industry: Biotechnology Target Price = $ 0.24 Recommendation: SUPER MEGA BUY
There are many reasons to buy into (XKEM) $DO YOUR DD A HUGE WINNER HERE $ Once News on the Approval of the NIGERIA plant comes out SKY HIGH SHE GOES . Charts speak for them selfs RSI strong buy
Posted by: thewallmaster In reply to: None Date:2/24/2006 8:26:20 AM Post #of 323
XKEM -- BUY CONFIRMED ---- HOLD HOLD HOLD Owners need shares they lost control of the compàny , WUND is the key !!!! Don’t SELL UNDER 0.05 cents , all parts need shares !!!!!!!
Look my analysis carefully:
With aprox numbers
first XKEM had 250 million shares O/S (aprox) that is float 125 million shares (the others 125 million shares of the owners)
but XKEM paid Alembic in shares 250 million again aprox (47% of the company) convertable and restricted (new O/S 500 million)
that means new numbers Alembic 47% / XKEM 53% (but 25% owners and 28% float)
Alembic is the new owner has control of the company last owners lost THE CONTROL
Well Alembic need shares to complete 51% but XKEM first owners need shares too to complete an important number
*important is that they are going to pay the ask price always, need the shares (yes WUND only buy don`t sell one share) and drying all the float...they are desperate and if they know good news coming and people know the plan (don`t sell) expect a BOOOOOOOOOOOOMMMMMMMMMM!!!!!
-------------------- Buy Low. Sell High. Posts: 10754 | From: The Land Of The Giants | Registered: Feb 2005
| IP: Logged |
posted
sounds sketchy man, take your profits by the end of the day would be my advice
Posts: 679 | From: New York | Registered: Jan 2006
| IP: Logged |
posted
XKEM,has a knockoff cancer drug coming to market soon, also has a Sickel Cell drug out this quarter.Just won a law suit against Brystol Myers, which in itself is impressive for a penny stock company to win against one of the giant drug manufacturers. This stock should have news out this week or next week regarding the Sickell Cell drug coming to market. I like the potential of XKEM.
Posted by: dawg245 In reply to: thewallmaster who wrote msg# 319 Date:2/24/2006 5:12:35 PM Post #of 331
What impresses me is that XKEM went head to head with Bristol-Myers........and won. Now, if the sickle cell drug expands from Nigeria to the rest of the world we will all be rich, very rich.
TAKE THAT NAKED SHORTERS -----------------------------------------------
XKEM buy alert The SouthEnd Stock Pickers helps investors win at investing on the merits of radically original thinking and an unbeatable track record of picking stocks with huge potential. We're here for you with commonsense, the big ideas, and a little inspiration to turn your portfolio into a monster performer. We've brought you GTE, GOOG, SIRI, CMGI, JDSU,HISC, and others you've made a killing on! If it doesn't make commonsense, it makes nosense to us or you.
At SouthEnd Stock Pickers, we're focusing solely on undervalued Nasdaq stocks that we feel will return potential profits of 500%+ in 1 to 3 weeks. Our New picks have hours and hours of research listed below.Our SouthEnd Team uses a new breakthrough method of hardcore stock picks.$$ WE ARE HERE TO MAKE YOU MONEY $$
Our new pick for 22/FEB/2006 is =(XKEM) was picked up of (INSIDER BUYING)
Accumulation........is the key word
Xechem International,Inc,
Ticker Symbol = XKEM
Market Cap = $ 1. 90M
Industry: Biotechnology
Target Price = $ 0.24
Recommendation: SUPER MEGA BUY
There are many reasons to buy into (XKEM) $DO YOUR DD A HUGE WINNER HERE $
Once News on the Approval of the NIGERIA plant comes out SKY HIGH SHE GOES .
posted
Xechem Completes Repurchase of $3 Million Convertible Loan From Alembic Thursday January 12, 6:30 am ET Alembic Surrenders 15% Equity Stake in Xechem's Nigerian Subsidiary and Broad Royalty Rights Under New Agreement
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Jan. 12, 2006--Xechem International, Inc. (OTC BB: XKEM - News) Xechem International announced today it has completed a comprehensive restructuring of its $3 million convertible loan with Alembic Limited, an Indian pharmaceutical company that had invested in Xechem in 2003. At the time of the original financing, Alembic received a substantial equity stake in Xechem and its Nigerian subsidiary, Xechem Pharmaceuticals Nigeria Limited, as well as the right to receive a gross royalty of 15% of Xechem Nigeria's total sales of NICOSAN(TM), the promising drug being developed by Xechem for the treatment of Sickle Cell Disease. Under the old financing arrangement, Alembic also was entitled to a 1% export fee for all revenues generated outside of Nigeria from the sale of the Company's sickle cell drug, 10 million warrants to purchase Xechem's common stock, and a right of first refusal for the distribution rights in Africa and India from the sale of its sickle cell drug. The loan had an original maturity date of April 2008, and was convertible at any time by Alembic into common stock of Xechem at a substantial discount to the then-current market price for the stock. ADVERTISEMENT
Transaction Dramatically Enhances Xechem's Bottom Line Potential From Sale Of NICOSAN(TM), Xechem's Sickle Cell Drug
Under the broad restructuring announced by Xechem, the amount of Xechem's obligation to Alembic remains unchanged at $3 million. However, in exchange for accelerated repayment terms, which include paying Alembic $1 million later this month with full repayment moved up to year-end 2006, as well as Xechem's pledge of certain collateral, Alembic has agreed to terminate all existing agreements, rights and obligations under the old loan arrangement, including its 15% equity interest in the Xechem Nigeria subsidiary, the gross royalty stream from both the Nigerian and U.S. operations, the warrants to purchase Xechem International stock and the right to convert its debt into Common Stock of Xechem.
Dr. Ramesh C. Pandey, the Chairman and Chief Executive Officer of both Xechem International and its Nigerian subsidiary, said "For quite some time, we have been looking for a way to restructure the Alembic indebtedness in a manner that would allow us reclaim the equity stake in our Nigerian subsidiary and the royalty stream that was part of the package of rights transferred to Alembic at the time of the original loan. Alembic expressed a willingness to accommodate our desire as long as the repayment schedule was improved upon and certain collateral was posted. In the deal that was agreed to, Alembic got what it wanted, which was improved repayment terms and a measure of collateral, and we have again taken full control of our Nigerian subsidiary with the termination of broad rights and understandings that previously belonged to Alembic. I believe this truly was a win-win situation for both parties." Dr. Pandey went on to add that Alembic's return to Xechem of the equity stake in the Xechem Nigeria subsidiary and the gross royalty rights it previously held "should greatly enhance the prospects and bottom line success of our Nigerian and U.S. operations and may also increase the likelihood of our attracting private investment or raising money through the public markets, both in Nigeria and elsewhere."
-------------------- Buy Low. Sell High. Posts: 10754 | From: The Land Of The Giants | Registered: Feb 2005
| IP: Logged |
WUND is still buying up all the shares he can get his grredy little mits on.
There may be some validity to this post after seeing WUND the past few days:
Posted by: thewallmaster In reply to: None Date:2/24/2006 8:26:20 AM Post #of 323
XKEM -- BUY CONFIRMED ---- HOLD HOLD HOLD Owners need shares they lost control of the compàny , WUND is the key !!!! Don’t SELL UNDER 0.05 cents , all parts need shares !!!!!!!
Look my analysis carefully:
With aprox numbers
first XKEM had 250 million shares O/S (aprox) that is float 125 million shares (the others 125 million shares of the owners)
but XKEM paid Alembic in shares 250 million again aprox (47% of the company) convertable and restricted (new O/S 500 million)
that means new numbers Alembic 47% / XKEM 53% (but 25% owners and 28% float)
Alembic is the new owner has control of the company last owners lost THE CONTROL
Well Alembic need shares to complete 51% but XKEM first owners need shares too to complete an important number
*important is that they are going to pay the ask price always, need the shares (yes WUND only buy don`t sell one share) and drying all the float...they are desperate and if they know good news coming and people know the plan (don`t sell) expect a BOOOOOOOOOOOOMMMMMMMMMM!!!!!
-------------------- Buy Low. Sell High. Posts: 10754 | From: The Land Of The Giants | Registered: Feb 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
